Immune to Cancer: The CRI Blog
-
Stomach Cancer Awareness Month: 2021 Immunotherapy Research Updates
This November for Stomach Cancer Awareness Month, let’s look at the latest treatments, research insights, and we're…
-
Stomach Cancer Awareness Month: 2020 Immunotherapy Research Updates
This November for Stomach Cancer Awareness Month, we look at new research, new treatments, and how we’re…
-
Stomach Cancer Awareness Month: 2019 Immunotherapy Research Update
We round up the latest immunotherapy for stomach cancer news and research from the scientists, physicians, and…
-
Checkpoint Immunotherapy Approved for Patients with Stomach, Gastroesophageal, and Liver Cancer
Previously treated patients with these cancer types can now receive anti-PD-1 immunotherapy; nivolumab for HCC and pembrolizumab…
-
Immunotherapy Shows Promise Against Previously Untreatable Stomach Cancer
Nivolumab improves survival in patients with advanced stomach cancer.